News

BIOTRONIK, the leading manufacturer of cardiovascular medical technology celebrating its 50th anniversary this year, gains market approval (CE-approval) for the most advanced ICD/CRT-D (cardioverter-defibrillator/cardiac resynchronization...

Endosense, a pioneer and leader in contact-force sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced that the results of its EFFICAS I prospective...

GE Healthcare announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView™ (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent to link nerve function in the heart to a...

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced it received U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE)...

St. Jude Medical, Inc., a global medical device company, announced publication of results from its landmark RESPECT trial in The New England Journal of Medicine. The study results show that device closure using the AMPLATZER™ PFO Occluder is...

SAN FRANCISCO, CALIFORNIA, March 9, 2013 – Today at the American College of Cardiology (ACC) conference, GE Healthcare confirmed its commitment to cardiovascular care by introducing new products and solutions as well as showcasing its current...

iRhythm Technologies, Inc., a medical device, service and technology company that develops and markets simple, innovative diagnostic monitoring solutions, announced clinical study findings showing that use of the Zio® Patch resulted in a...

St. Jude Medical, Inc., a global medical device company, announced the first patient implant in a new pivotal trial evaluating the company’s AMPLATZER™ Cardiac Plug (ACP) for the prevention of stroke. The AMPLATZER™ Cardiac Plug Clinical...

Endosense, a pioneer and leader in contact-force sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, announced that it has secured an additional USD 4.3 million/CHF 4...

CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announces that its technology will be discussed at the 3rd Annual Frankfurt Atrial Fibrillation Academy (FAFA), to be...